Detalles de la búsqueda
1.
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
J Neuroinflammation
; 15(1): 19, 2018 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29338785
Resultados
1 -
1
de 1
1
Próxima >
>>